Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNAs as Biomarkers of Charcot-Marie-Tooth Disease Type 1A

24 May 2021

Abstract excerpt

OBJECTIVE: To determine whether microRNAs (miRs) are elevated in the plasma of individuals with the inherited peripheral neuropathy Charcot-Marie-Tooth disease type 1A (CMT1A), miR profiling was employed to compare control and CMT1A plasma. METHODS: We performed a screen of CMT1A and control plasma samples to identify miRs that are elevated in CMT1A using next-generation sequencing, followed by validation of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hereditary Neurological Disorders
Share to Nerve injury and regeneration
Share to Peripheral Neuropathies and Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34031204
DOI: 10.1212/wnl.0000000000012266

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MicroRNAs as Biomarkers of Charcot-Marie-Tooth Disease Type 1APMID 34031204Read ↗

Circulating transcriptional biomarkers serve as surrogates of disease progression in Charcot-Marie-Tooth 1A diseaseSemantic proximity Read ↗

Charcot-Marie-Tooth neuropathies: diagnosis and management.Semantic proximity Read ↗

Update on Charcot–Marie–Tooth diseaseSemantic proximity Read ↗

Molecular mechanisms, diagnosis, and rational approaches to management of and therapy for Charcot-Marie-Tooth disease and related peripheral neuropathies.Semantic proximity Read ↗

A brief review of recent Charcot-Marie-Tooth research and prioritiesSemantic proximity Read ↗

CMT1A current gene therapy approaches and promising biomarkersSemantic proximity Read ↗

Peripheral neuropathies: Molecular diagnosis of Charcot-Marie-Tooth disease.Semantic proximity Read ↗

Emerging Therapies for Charcot-Marie-Tooth Inherited Neuropathies.Semantic proximity Read ↗

Recent advances in the genetic neuropathies.Semantic proximity Read ↗

Molecular diagnostics of Charcot-Marie-Tooth disease and related peripheral neuropathies.Semantic proximity Read ↗

Charcot-Marie-Tooth disease: an updateSemantic proximity Read ↗

Challenges in Treating Charcot-Marie-Tooth Disease and Related Neuropathies: Current Management and Future PerspectivesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.